BACITRACIN Drug Patent Profile
✉ Email this page to a colleague
When do Bacitracin patents expire, and when can generic versions of Bacitracin launch?
Bacitracin is a drug marketed by Lilly, Padagis Us, Pharmaderm, Pharmafair, Combe, Naska, Apothekernes, Paddock Llc, Bausch And Lomb, Sciegen Pharms Inc, and Altana. and is included in seventeen NDAs.
The generic ingredient in BACITRACIN is bacitracin zinc; hydrocortisone acetate; neomycin sulfate; polymyxin b sulfate. There are twenty-seven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the bacitracin zinc; hydrocortisone acetate; neomycin sulfate; polymyxin b sulfate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for BACITRACIN?
- What are the global sales for BACITRACIN?
- What is Average Wholesale Price for BACITRACIN?
Summary for BACITRACIN
| US Patents: | 0 |
| Applicants: | 11 |
| NDAs: | 17 |
| Finished Product Suppliers / Packagers: | 1 |
| Clinical Trials: | 31 |
| Drug Prices: | Drug price information for BACITRACIN |
| DailyMed Link: | BACITRACIN at DailyMed |
Recent Clinical Trials for BACITRACIN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Ohio State University | N/A |
| Cairo University | Early Phase 1 |
| University of Turin, Italy | N/A |
Pharmacology for BACITRACIN
| Physiological Effect | Decreased Cell Wall Synthesis & Repair |
Medical Subject Heading (MeSH) Categories for BACITRACIN
Anatomical Therapeutic Chemical (ATC) Classes for BACITRACIN
US Patents and Regulatory Information for BACITRACIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lilly | BACITRACIN | bacitracin | OINTMENT;OPHTHALMIC | 060687-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Apothekernes | BACITRACIN | bacitracin | POWDER;FOR RX COMPOUNDING | 061699-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Pharmafair | BACITRACIN | bacitracin | OINTMENT;OPHTHALMIC | 062453-001 | Mar 28, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Pharmafair | BACITRACIN ZINC-NEOMYCIN SULFATE-POLYMYXIN B SULFATE | bacitracin zinc; neomycin sulfate; polymyxin b sulfate | OINTMENT;OPHTHALMIC | 062386-001 | Sep 9, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Paddock Llc | BACITRACIN | bacitracin | POWDER;FOR RX COMPOUNDING | 062456-001 | Jul 27, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Altana | BACITRACIN-NEOMYCIN-POLYMYXIN W/ HYDROCORTISONE ACETATE | bacitracin; hydrocortisone acetate; neomycin sulfate; polymyxin b sulfate | OINTMENT;OPHTHALMIC | 060731-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Naska | BACITRACIN ZINC-POLYMYXIN B SULFATE | bacitracin zinc; polymyxin b sulfate | OINTMENT;TOPICAL | 062849-001 | Nov 13, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
